[P61] Poster Session 61　Lung Cancer/Thoracic Cancer（ICI efficacy 2）

[P61-5] Examination of patients with advanced non-small cell lung cancer（NSCLC）responding to nivolumab monotherapy over 1 year

^○Saki Nakajima¹, Satoshi Watanabe^1,2, Takuhide Utsunomiya^1,2, Kiyokazu Yoshinoya^1,2, Hidehiro Honda^1,2, Suguru Yamamoto², Keita Kudo¹ (1.Department of Thoracic Medical Oncology, National Hospital Organization, Osaka Minami Medical Center, 2.Department of Respiratory Medicine, National Hospital Organization, Osaka Minami Medical Center)